A multicenter phase II study of gemcitabine and oxaliplatin for malignant pleural mesothelioma.

@article{Schutte2003AMP,
  title={A multicenter phase II study of gemcitabine and oxaliplatin for malignant pleural mesothelioma.},
  author={Wolfgang Schutte and Thomas Blankenburg and Kathrin Lauerwald and J. H. Schreiber and Ines Bork and Bettina Wollscgkaeger and Dorothea Treutler and C P Schneider and Reiner Bonner},
  journal={Clinical lung cancer},
  year={2003},
  volume={4 5},
  pages={294-7}
}
We conducted a phase II multicenter trial to evaluate the activity of combined gemcitabine and oxaliplatin in malignant pleural mesothelioma. Twenty-five patients were recruited between May 1999 and December 2001 and received gemcitabine 1000 mg/m2 intravenously over 30 minutes and oxaliplatin 80 mg/m2 intravenously over 3 hours on days 1 and 8 of a 21-day cycle for a maximum of 6 cycles. Eligibility criteria included an Eastern Cooperative Oncology Group performance status of 0-2 and no prior… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

Similar Papers

Loading similar papers…